Skip to main content
OpenTrials

Clinical trial condition

Gaucher Disease

Explore clinical trials studying Gaucher Disease. Study availability and eligibility vary by location and protocol.

131 public trials 25 recruiting studies
Refine in advanced search Browse all conditions

Gaucher Disease trial results

Completed

Multicenter Extension Study of Velaglucerase Alfa in Japanese Patients With Gaucher Disease

NCT01842841

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations
  • Hamamatsu University School of Medicine Hamamatsu, Shizuoka, Japan
  • Iwata City Hospital Ōkubo, Shizuoka, Japan
  • The Jikei University School of Medicine Minato-ku, Tokyo, Japan
  • Chiba Children's Hospital Chiba, Japan
View Trial Details
Completed

Efficacy and Safety Study of Velaglucerase Alfa in Children and Adolescents With Type 3 Gaucher Disease

NCT01685216

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
Locations
  • Alexandria University Hospital Alexandria, Egypt
  • Abu El Rich Hospital, Cairo University Hospital Cairo, Egypt
  • Children's Hospital, Ain Shams University Hospital Cairo, Egypt
  • KEM Hospital Research Centre Pune, Maharashtra, India
View Trial Details
Completed

An Open-Label Extension Study of GA-GCB ERT in Patients With Type 1 Gaucher Disease

NCT00635427

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
Locations
  • Los Angeles Medical Center Los Angeles, California, United States
  • Children's Hospital Oakland Oakland, California, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
  • Children's Memorial Hospital Chicago, Illinois, United States
View all 21 locations
View Trial Details
Completed

Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase

NCT00478647

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations
  • Regional Metabolic Center Los Angeles, California, United States
  • Children's Hospital Oakland Oakland, California, United States
  • Emory University Decatur, Georgia, United States
  • Feinberg School of Medicine Chicago, Illinois, United States
View all 15 locations
View Trial Details
Completed

Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) ERT Compared With Imiglucerase in Type I Gaucher Disease

NCT00553631

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +15 more
Locations
  • Duke Children's Hospital & Health Center Durham, North Carolina, United States
  • Your Health S.A. Buenos Aires, Argentina
  • Malabar Institute of Medical Sciences Ltd. Calicut, Kerala, India
  • All India Institute of Medical Sciences New Delhi, India
View Trial Details
Completed

Lyso-Gb1 as a Long-term Prognostic Biomarker in Gaucher Disease

NCT02416661

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +16 more
Locations
  • University Hospital Center Mother Teresa Tirana, Albania
  • Aristotle University of Thessaloniki, Ippokration General Hospital Thessaloniki, Greece
  • Centre for Human Genetics Bangalore, India
  • Shaare Zedek Medical Center Jerusalem, Israel
View Trial Details
Completed

Home Therapy With VPRIV in Gaucher's Disease

NCT01356537

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations
  • Landeskrankenhaus Bregenz Bregenz, Austria
  • Paracelsus Medizinische Privatuniversität Salzburg Salzburg, Austria
  • AKH, Allgemeines Krankenhaus der Stadt Wien Vienna, Austria
  • Medical University of Vienna Vienna, Austria
View Trial Details

Related conditions